Human Gene Expression Patterns Associated with Experimental P. falciparum Infection

ANALYTE_TYPE - Analyte type (phv00283969.v1.p1)
BODY_SITE - Body site where sample was collected (phv00283968.v1.p1)
CLINICAL_OUTCOME - Clinical outcome after challenge (phv00283976.v1.p1)
CONSENT - Consent group as determined by DAC (phv00283957.v1.p1)
GROUP - Experimental stage (phv00283973.v1.p1)
HISTOLOGICAL_TYPE - The type of sample, cell or tissue type or subtype of the sample (phv00283970.v1.p1)
IS_TUMOR - Tumor status of the sample (phv00283971.v1.p1)
SAMPLE_ID - De-identified sample ID (phv00283967.v1.p1)
SAMPLE_ID - Sample ID (phv00283961.v1.p1)
SAMPLE_SOURCE - Source repository where samples originate (phv00283962.v1.p1)
SAMPLE_USE - Sample Use (phv00283964.v1.p1)
SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00283972.v1.p1)
SOURCE_SAMPLE_ID - Sample ID used in the Source Repository (phv00283963.v1.p1)
SOURCE_SUBJECT_ID - Subject source ID (phv00283959.v1.p1)
SUBJECT_ID - Subject ID (phv00283960.v1.p1)
SUBJECT_ID - Subject ID (phv00283956.v1.p1)
SUBJECT_ID - De-identified subject ID (phv00283965.v1.p1)
SUBJECT_SOURCE - Subject source (phv00283958.v1.p1)
TIME_POINT - Time point of sample collection (phv00283974.v1.p1)
VACCINATION_GROUP - Type of vaccination (phv00283975.v1.p1)